Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children’s Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |
Generation of CHD5 Antibodies and Know-out Mouse Model
|
Children’s Hospital of Philadelphia / Garrett Brodeur |
Innovation Grants |
2008 |
Pennsylvania |
In-UTR Mutations in Neuroblastoma: Functional Consequences and Therapeutic Implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko |
Innovation Grants |
2010 |
Pennsylvania |
Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells |
Children’s Hospital of Pittsburgh / Erica Braverman, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting |
Children’s Hospital of Philadelphia / Kristopher Bosse, MD |
'A' Award Grants |
2022 |
Pennsylvania |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |
Mechanisms Regulating Medulloblastoma Progression |
University of Pennsylvania / Nadia Dahmane, PhD |
Innovation Grants |
2013 |
Pennsylvania |
Epigenomic Mechanisms of Neuroblastoma Tumorigenesis |
Children’s Hospital of Philadelphia / Jo Lynne Harenza, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |